March 3, 2026
TOPLINE: A notable proportion of patients with Cushing syndrome (CS) experienced depression. Pain and body image disturbances were significantly associated with persistent depression, and this relationship […]
March 3, 2026
Orforglipron, a novel oral nonpeptide GLP-1 receptor agonist (RA), led to a greater reduction in A1c and more significant weight loss compared to oral semaglutide in […]
March 2, 2026
A daily pill could soon challenge monthly depot injections as standard therapy for acromegaly in Europe. At its February meeting, the European Medicines Agency’s (EMA’s) Committee […]
March 2, 2026
The US FDA has approved Novo Nordisk’s once-weekly growth hormone somapacitan-beco (Sogroya) for three new pediatric indications. The injectable long-acting growth hormone, in doses of 5 […]
February 27, 2026
Adults with insulin-treated diabetes and mental health conditions face serious safety risks, a national investigation has found. Gaps between specialist services are exposing some patients to […]
February 26, 2026
TOPLINE: Among patients with type 1 diabetes (T1D) and obesity, metabolic bariatric surgery was associated with significant weight loss, lower insulin requirements, a modest reduction in […]
February 26, 2026
TOPLINE: Among US adolescents aged 10-19 years, roughly 30% have prediabetes or type 2 diabetes (T2D), with boys accounting for 62% of cases. Abdominal adiposity, measured […]
February 24, 2026
Can intermittent fasting help people who have overweight lose weight? It is likely that intermittent fasting is not superior to other diets for weight loss and […]
February 24, 2026
SARS-CoV-2 infection appeared to raise the risk for all forms of new-onset thyroid disease in people who needed hospital care due to COVID and those who […]